Patents by Inventor Stephanie Moeller

Stephanie Moeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11015118
    Abstract: The present disclosure relates to a phosphor ceramic comprising a plurality of luminescence conversion materials, wherein a luminescence conversion material serves as a matrix material for the others.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: May 25, 2021
    Assignee: Seaborough IP I B.V.
    Inventors: Thomas Jüstel, Stephanie Möller, Florian Baur, Nadja Kratz, Jan Werner, Murat Demirtas, Jürgen Honold, Tom Hilgerink
  • Patent number: 10131839
    Abstract: A high-energy LED is provided, in particular based on the n-polar technique, comprising a Eu3+ activated converter material based on tungsten/molybdenum oxide. Surprisingly, these materials do not show any saturation.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: November 20, 2018
    Inventors: Thomas Jüstel, Julian Plewa, Stephanie Möller, Jürgen Honold
  • Publication number: 20180171225
    Abstract: The present disclosure relates to a phosphor ceramic comprising a plurality of luminescence conversion materials, wherein a luminescence conversion material serves as a matrix material for the others.
    Type: Application
    Filed: June 24, 2016
    Publication date: June 21, 2018
    Inventors: Thomas JÜSTEL, Stephanie MÖLLER, Florian BAUR, Nadja KRATZ, Jan WERNER, Murat DEMIRTAS, Jürgen HONOLD, Tom HILGERINK
  • Publication number: 20170253798
    Abstract: A high-energy LED is provided, in particular based on the n-polar technique, comprising a Eu3+ activated converter material based on tungsten/molybdenum oxide. Surprisingly, these materials do not show any saturation.
    Type: Application
    Filed: September 10, 2015
    Publication date: September 7, 2017
    Inventors: THOMAS JÜSTEL, JULIAN PLEWA, STEPHANIE MÖLLER, Jürgen HONOLD
  • Patent number: 8088304
    Abstract: The invention relates to phosphors having a garnet structure of the formula I (Ya,Gdb,Luc,Sed,Sme,Tbf,Prg,Thh,Iri,Sbj,Bik)3-x(All,Gam)5O12:Cex??(I) where a+b+c+d+e+f+g+h+i+j+k=1 l+m=1 and x=0.005 to 0.1, and to a process for the preparation of these phosphors, and to the use thereof as conversion phosphors for conversion of the blue or near-UV emission from an LED.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: January 3, 2012
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Holger Winkler, Tim Vosgroene, Thomas Juestel, Stephanie Moeller
  • Publication number: 20100084962
    Abstract: The invention relates to phosphors having a garnet structure of the formula I (Ya,Gdb,Luc,Sed,Sme,Tbf,Prg,Thh,Iri,Sbj,Bik)3-x(All,Gam)5O12:Cex??(I) where a+b+c+d+e+f+g+h+i+j+k=1 l+m=1 and x=0.005 to 0.1, and to a process for the preparation of these phosphors, and to the use thereof as conversion phosphors for conversion of the blue or near-UV emission from an LED.
    Type: Application
    Filed: February 13, 2008
    Publication date: April 8, 2010
    Applicant: MERCK PATENT GESELLSCHAFT
    Inventors: Holger Winkler, Tim Vosgroene, Thomas Juestel, Stephanie Moeller
  • Publication number: 20070238167
    Abstract: The present invention relates to culturing cells utilizing a matrix of microfibrillated thermoplastic polymeric materials. More specifically, the present invention relates to a method of culturing cells. In addition, the invention relates to a microfibrillated article for culturing cells dispersed in a cell culture medium. The matrix of thermoplastic polymeric materials for culturing cells of this invention finds use in tissue engineering and wound healing applications.
    Type: Application
    Filed: April 4, 2006
    Publication date: October 11, 2007
    Inventors: Mario Perez, Terry Hobbs, Stephanie Moeller
  • Publication number: 20070231362
    Abstract: The present invention relates to culturing cells utilizing a matrix of microfibrillated thermoplastic polymeric materials. More specifically, the present invention relates to a method of culturing cells. In addition, the invention relates to a microfibrillated article for culturing cells dispersed in a cell culture medium. The matrix of thermoplastic polymeric materials for culturing cells of this invention finds use in tissue engineering and wound healing applications.
    Type: Application
    Filed: April 4, 2006
    Publication date: October 4, 2007
    Inventors: Mario Perez, Terry Hobbs, Stephanie Moeller
  • Publication number: 20070054878
    Abstract: Rheumatoid arthritis is a chronic inflammatory disease, leading to joint destruction. Conventional therapy is based on pain-reduction and an improvement in the frictional properties of joints, in order to delay the time for operative intervention. A lack of specifically-acting agents for drug-based therapy for arthritis exists. The formulations comprise sulphated hyaluronic acids with varying degrees of sulphation, or the pharmacologically acceptable salts thereof and, optionally, hyaluronic acid and/or hyaluronic acid uronide. The pharmaceutical formulations are highly concentrated injection preparations with an aqueous, viscous, gel-like, or paste-like form, or a low-concentration rinsing fluid for intra-articular application.
    Type: Application
    Filed: October 16, 2006
    Publication date: March 8, 2007
    Inventors: Rudolf Venbrocks, Andreas Roth, Peter-Juergen Mueller, Stephanie Moeller, Joerg Ozegowski, Gundela Peschel
  • Publication number: 20040053885
    Abstract: Rheumatoid arthritis is a chronic inflammatory disease, leading to joint destruction. Conventional therapy is based on pain-reduction and an improvement in the frictional properties of joints, in order to delay the time for operative intervention. A lack of specifically-acting agents for drug-based therapy for arthritis exists. The formulations comprise sulphated hyaluronic acids with varying degrees of sulphation, or the pharmacologically acceptable salts thereof and, optionally, hyaluronic acid and/or hyaluronic acid uronide. The pharmaceutical formulations are highly concentrated injection preparations with an aqueous, viscous, gel-like, or paste-like form, or a low-concentration rinsing fluid for intra-articular application.
    Type: Application
    Filed: July 21, 2003
    Publication date: March 18, 2004
    Inventors: Rudolf Venbrocks, Andreas Roth, Peter-Juergen Mueller, Stephanie Moeller, Joerg Ozegowski, Gundela Peschel